July 23, 2026 03:04 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'We won't leave Jantar Mantar until Dharmendra Pradhan resigns': CJP draws red line | 'Don't waste our time': Supreme Court snubs plea on NEET protest crackdown | Trump's 200% tariff bomb on generic drugs: Here's how India could be hit | Rahul Gandhi, Priyanka Gandhi Vadra lead Congress march to PM Modi's residence over student protest crackdown | 'We can't ignore his concerns': Delhi HC gives Sonam Wangchuk big relief, clears shift to private hospital | 'Students are being tortured': Mamata Banerjee offers to join CJP protest in Delhi | Sikkim tunnel horror: 8 dead, several feared trapped after NHPC project collapse | As NEET protests intensify, PM Modi defends govt action, calls for 'foolproof' education system | After NEET storm, Modi govt faces fresh challenge as farmers march to Delhi over India-US trade deal | Jantar Mantar reclaimed! CJP defies overnight police eviction, returns to protest site

FIR against Snapdeal CEO for selling prescription drugs online

| | May 01, 2015, at 11:58 pm
Mumbai, May 1 (IBNS) Maharashtra's Food and Drugs Administration (FDA) has ordered that a First Information Report (FIR) be filed against Kunal Bahl, the CEO of e-commerce giant Snapdeal.com, for the sale of prescription drugs online.
FDA commissioner Harshadeep Kamble said on Friday said the FIR has been ordered against  Bahl and directors of the company.
 
The FDA said it had received information about the alleged sale of a cough syrup, and certain tablets, both prescription drugs that can be sold only when prescribed by medical practitioner.
 
The FDA had issued a notice to the company asking it to delist the drugs and also furnish details of the drugs it offered for sale on the portal Snapdeal.com.
 
In a statement on Friday, Snapdeal said they are assisting in the probe and have delisted the products.
 
"In this matter, we are assisting the FDA team in this investigation and we will continue to do so. We have already delisted the products and said sellers and also stopped payment, in addition to providing all information to the FDA team as required by them," the statement said.
 
The FDA has said it is also checking to see if other e-retailers have sold drugs online.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.